These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9990251)

  • 1. Placebos and relapse in depression.
    Harv Ment Health Lett; 1999 Feb; 15(8):7. PubMed ID: 9990251
    [No Abstract]   [Full Text] [Related]  

  • 2. Prozac vs. placebos.
    Noonan D; Cowley G
    Newsweek; 2002 Jul; 140(3):48-9. PubMed ID: 12150021
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial.
    Ruddell M; Spencer A; Hill K; House A
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):963-5. PubMed ID: 17624914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European agency approves use of fluoxetine for children and teens.
    Eaton L
    BMJ; 2006 Jun; 332(7555):1407. PubMed ID: 16777864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Seizures crisis following sudden stop of fluoxetine].
    Epelde F; Plà R; Aguilar M
    Med Clin (Barc); 1999 Oct; 113(12):479. PubMed ID: 10570524
    [No Abstract]   [Full Text] [Related]  

  • 6. Going beyond Prozac.
    Miller MC
    Newsweek; 2003 Dec; 142(23):69-70. PubMed ID: 14712565
    [No Abstract]   [Full Text] [Related]  

  • 7. Out of the dumps by blocking the serotonin pump.
    Indian J Physiol Pharmacol; 1995 Oct; 39(4):313. PubMed ID: 8582741
    [No Abstract]   [Full Text] [Related]  

  • 8. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
    Nierenberg AA; Pava JA; Clancy K; Rosenbaum JF; Fava M
    Biol Psychiatry; 1996 Oct; 40(8):691-6. PubMed ID: 8894060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder.
    Lam RW; Gorman CP; Michalon M; Steiner M; Levitt AJ; Corral MR; Watson GD; Morehouse RL; Tam W; Joffe RT
    Am J Psychiatry; 1995 Dec; 152(12):1765-70. PubMed ID: 8526243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression: epidemic or pseudo-epidemic?
    Hafizi S
    J R Soc Med; 2006 Sep; 99(9):436. PubMed ID: 16946381
    [No Abstract]   [Full Text] [Related]  

  • 12. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N; van Nieuwenhuizen A; Clain A; Baer L; Nierenberg AA
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine-induced SIADH: most likely in the elderly?
    Burke D; Franker S
    Aust N Z J Psychiatry; 1996 Apr; 30(2):299-301. PubMed ID: 8811278
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine versus placebo in advanced cancer outpatients.
    Alliot C
    J Clin Oncol; 2004 Jan; 22(1):204-5; author reply 206-8. PubMed ID: 14701790
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of habit-tic deformity with fluoxetine.
    Vittorio CC; Phillips KA
    Arch Dermatol; 1997 Oct; 133(10):1203-4. PubMed ID: 9382557
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore.
    Tsoi WF; Tan CT; Kok LP
    Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
    Simon JS; Aguiar LM; Kunz NR; Lei D
    J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dosage tricyclic antidepressants in depression. Giving low dose tricyclics is not justified by evidence.
    Jones HM
    BMJ; 2003 Mar; 326(7387):499; author reply 499. PubMed ID: 12609953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.